← FDA Drug Approvals (Drugs@FDA)

IMFINZI

BLA · Biologics License Application · Sponsor: ASTRAZENECA UK LTD · Approved 2017-05-01

Drug application

FDA Application #
BLA761069
Application type
Biologics License Application
Brand name
IMFINZI
Generic name
DURVALUMAB
Active ingredients
DURVALUMAB
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
ASTRAZENECA UK LTD
Manufacturer
AstraZeneca Pharmaceuticals LP
First approval
2017-05-01

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown